PortViewPortView
Cellect Biotechnology logo

Cellect Biotechnology (APOP) Stock Analysis

NASDAQHealthcareBiotechnology

$13.17+0.38%
1-year price historyRange $12.83 – $26.80
52-week range$13.17
$1.75$29.80

What Cellect Biotechnology does

Cellect Biotechnology Ltd. (NASDAQ: APOP) is a Biotechnology company in the Healthcare sector.

Key metrics

Market cap
$129.02M
P/E (TTM)
-15.42
EPS (TTM)
$-0.85
Beta
1.88
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$17.38
200-day avg
$7.39
52-week high
$29.80
52-week low
$1.75
CEO
Shai Yarkoni

ETFs linked to APOP

Broad-market and Healthcare sector ETFs an investor holding Cellect Biotechnology is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how APOP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze APOP in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Cellect Biotechnology?
Cellect Biotechnology trades under the ticker APOP on NASDAQ.
Which exchange is APOP listed on?
APOP is listed on NASDAQ.
What sector does Cellect Biotechnology operate in?
Cellect Biotechnology is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze APOP in a portfolio?
PortView shows APOP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.